List of Clinical Research Companies in United States - 180

3Daughters is a clinical development company focused on enhancing women’s healthcare through innovative contraceptive solutions. The company aims to fill critical gaps in women's health by developing research-driven products that prioritize patient safety, efficacy, and accessibility. Their flagship products include 3D-001, a frameless, nonhormonal intrauterine device (IUD) designed to reduce insertion pain, and the Slider™ System, which features the i-Slider™ for insertion and the r-Slider™, a magnetic retriever for easy placement and removal. This technology leverages physics and geometry to improve comfort and minimize complications associated with traditional IUDs. 3Daughters targets women seeking reliable, long-acting contraception, particularly those who may be deterred by pain or hormonal side effects. The company has secured over $2 million in seed funding to advance its products through clinical trials, with a commitment to regulatory compliance and quality management. Their mission is to transform women’s healthcare by improving contraceptive accessibility and comfort.

AAVnerGene Inc is an innovative company specialized in AAV technologies. It is founded by a group of AAV gene therapy enthusiasts who dream to serve the community, promote and lead the future of gene therapy. Our passion is to solve the bottleneck problems in AAV gene therapy and find more and better cures for all the patients. We believe that hard core technologies are the key to achieve it. With 20 years of frontline gene therapy experience, our team develops novel AAV vectors, methods and strategies that can efficiently produce, deliver and express high quality vectors into specific cells. Our goal is to increase AAV gene therapy efficacy and decrease the cost, making it accessible and affordable to patients. Our highly complex AAV capsid libraries allow us to efficiently select the best AAV capsid for each cell type in a high-throughput manner.

Abiologics is pioneering a new class of supranatural and programmable biologics, called Synteins™. The Abiologics platform leverages cutting-edge generative artificial intelligence and high-throughput chemical protein synthesis to create Synteins with powerful, desirable pharmacological properties, redefining what therapeutics can achieve for patients across a range of disease areas. Abiologics was founded by Flagship Pioneering in 2021.

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world's most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients' team – helping them advance today's ideas into tomorrow's medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.

ACRC, with locations in Austin, Carrollton, Frisco, Grapevine & Plano, conducts clinical trials with award-winning physicians. Our doctors are recognized by their peers, year after year, as D Magazine's "Best Doctors." Our team of physicians and research nurses provide convenient, accessible and high-quality patient care, all under one roof. Our goal is to advance medical knowledge and help introduce new and improved medications to the general public via pharmaceutical sponsored clinical research trials. We maintain an unwavering commitment to the highest level of ethical standards and safety. Participants go through a thorough medical checkup to determine qualification into a research study.

ActivMed Practices & Research, LLC. was founded in 1994 and is headquartered in Methuen, Massachusetts. The Company operates 4 clinical research offices. Methuen, Massachusetts headquarters, Beverly Massachusetts and in 2 in Portsmouth, New Hampshire. The proximity of the offices gives ActivMed Practices & Research access to nearly 1.7 million potential patients. Having successfully completed over 900 clinical trials, nationally recognized ActivMed Practices & Research has developed the staff, processes, recruitment practices and facilities to exceed performance expectations for Phase I, II, III and IV clinical trials. Our goal is to offer a compassionate, friendly, and positive research experience for our patients while gathering information that may benefit all of mankind. Awards & Citations: CorporateLiveWire Innovation & Excellence Awards, 2019 & 2018 Top 25 Places to Work, North of Boston, 2014 Business of the Year, Greater Haverhill Chamber of Commerce, 2012 Business of the Year, Greater Haverhill Healthcare, 2011 US House of Representatives Special Congressional Recognition, 2011 Massachusetts State Senate Health Award Citation, 2011 Office of the Mayor of Haverhill Official Citation, 2011 Our President and CEO Terry Stubbs has received the following awards and recognition: eWomen's "Made It To A Million"​ 2009 Women's Mentoring Award, Finalist Greater Haverhill Chamber of Commerce, Woman of the Year, Finalist, 2010 Who's Who in America, 2000-2004 Board of Director's Greater Haverhill Chamber of Commerce, 2000-2016 Public Speaker for Clinical Research Industry, 2007-Present

Adaptive Clinical Systems, a global life sciences technology company, offers a simple, secure, validated, compliant and cost-effective solution for data interoperability as well as reporting and visualization for clinical trials. Adaptive Clinical offers the Adaptive eClinical Bus and Adaptive DataVIEW. The Adaptive eClinical Bus®, a cloud-based hosted service, will integrate with any EDC, eCOA, CTMS, ePRO/IWRS, Medical Imaging, IRT, Analytics, Data Acquisition Systems as well as RWD, EHR/EMR to reduce error and speed data management for any size study. With the Adaptive eClinical Bus, patient- centric clinical trials can ensure interoperability and full compliance from the many diverse eSources generated from the explosion of data from Digital Health Technologies (DHTs), such as wearables and remote patient monitoring (RPM) solutions. Key benefits of the Adaptive eClinical Bus include: ✔️ Fully-validated Platform with Detailed Audit Logs and Reports ✔️ Fully compliant with HHS 45 CFR Part 64, FDA 21 CFR Part 11, GxP and other regulatory guidelines ✔️ Standards-based for Interoperability ✔️ Easily Implement an eSource Data Capture Workflow ✔️ Adaptive Rules Engine offers Built-in Clinical Intelligence ✔️ Reusable components for Quick Installation ✔️ Full training and 24/7 support Adaptive DataVIEW provides a robust solution for visualizing and analyzing data from disparate sources quickly and efficiently. It provides real-time, bi-directional data from many disparate sources into comprehensive dashboards. Purpose built for clinical trial operational key performance indicators and dashboards. Reports can be created at the patient, site, study or program level, including across studies. Adaptive DataVIEW enables "single click-back" from any widget or dashlet to the data source regardless of eClinical tool.

Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.

Advanced Pharma - Miami is a dedicated Phase I­-IV Clinical Research Facility. With our 40,000 sq. ft. turnkey facility we house a 100+ bed capacity Phase I unit with three 6-­8 bed IPUs (Intensive Procedural Units) as well as our Phase II­-IV group experts. Our principals have participated in clinical trials since 1992 and our team has 50-­plus years of combined research experience. Our multi-­specialty Physician Investigators enable us to engage in many aspects of Phase I­-IV Pharmaceutical, Bio­tech and Medical Device Trials. Our team of experts is dedicated to sustaining safe, ethical, high-quality medical research so sponsors can exceed their deadline and patients can benefit from the development of new treatments and therapies. We pride ourselves on bringing efficiency, innovation and value to the clinical research process. Our strict adherence to protocol and GCP standards, along with our uniform delivery of quality data guarantees the most efficient and timely outcome in all trials. Our historical patient data confirms that we have outstanding recruitment and retention percentages in the upper 90's.

Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.

Alpine Research is a Clinical Research Center that conducts clinical trials for major pharmaceutical companies.

CenExel ACT is dedicated to performing medical clinical trials to find new patient therapies in unique areas, including Japanese-and Chinese-bridging studies. Our Phase I Clinical Pharmacology Unit is a 30,000 SF, state-of-the-art, 90 beds, clinical research center, and features: Private patient rooms and ward setting, State of the art entertainment 24-hour medical coverage, 7 days a week, On-site Surgery Suite (2 Procedure Rooms, 3 Recovery Beds), Emergency Room and Intensive Care Unit located close by In the clinical trials area, we ffer investigational therapies for indications such as Migraines, Insomnia, Chronic Pain, Osteoporosis, Hormone Replacement Therapy, Diabetes and much more. We offer new and existing therapies that manage conditions where other medical therapies may have failed. Each and every CenExel patients receive the highest quality medical care. We notify the patient's primary care physician of enrollment and ongoing status and provide a full report at the conclusion of each study. To learn more about working with us as a Sponsor or CRO for your clinical trial visit CenExel.com/ACT or call 714-774-7777.

Andson Biotech is dedicated to advancing mass spectrometry workflows by enabling simple and fast sample-to-analysis workflows. Andson's DynaChip platform leverages advanced microfluidics packaged into an easy-to-use system to make sample prep for mass spec faster (and easier) for everyone. Our platforms are designed to be flexible - they couple with any commercial MS system for on-demand mass spec analysis with no expert training required. Our focus today is on improving sample preparation and workflow integration so that everyone can get more out of their mass spec.

About Anju Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company's flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients' lives. Customer First Our mission is to always be a customer-first organization, powered by a passionate team, providing best-value life science solutions paired with an excellent customer experience to simplify the complexities of life science information management. Driving Impactful Results Anju solutions are used by large, mid-sized, and small pharmaceutical companies, clinical research organizations (CROs), and medical device companies as well as full-service medical marketing, market research, and communications agencies. Our technologies facilitate data flow between our solutions and seamless communication with third-party systems, providing a unique opportunity for our customers to leverage critical information and drive impactful results. Experienced Leadership Anju is a portfolio company of Abry Partners, which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across their active funds.

Anodyne is a venture-backed, clinical-stage biotech company focused on simplifying chronic care for all stakeholders. We specialize in the transdermal delivery of multi-milligram doses and complex formulations, enabling easier access to both existing therapies and emerging large molecule treatments. The HeroPatch, our proprietary technology represents a breakthrough in drug delivery. By transdermally delivering large molecules, it enables tunable pharmacokinetic profiles, new formulations using APIs in dry form, room temperature stability, and combination therapies of next-generation therapeutics. Our product pipeline is dedicated to addressing the unmet needs of chronic diseases, with an initial focus on obesity. We are committed to delivering innovative solutions that significantly impact patients' lives. Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships, maximizing the commercial potential and clinical impact of our advanced drug delivery platform.

Get the professional care you deserve when you visit our ARC walk-in medical clinic. We specialize in treating acute illnesses and injuries without you having to make an appointment. You will receive the highest quality diagnosis with safe and effective treatments in a timely manner. We provide accurate and prompt lab work on site to ensure that you get the most appropriate treatment. You can also act as an important part of our research by volunteering as a study participant. ARC of Arkansas conducts Phase II-IV Clinical Trials, Registries and Health Outcome Studies which are aimed at finding new and better treatments for various medical conditions and diseases.

Drug discovery remains an expensive and time-consuming process. Promising compounds proceed through clinical trials only to have many fail before FDA approval. Aracari Biosciences aims to simplify this process by more accurately and efficiently evaluating promising drug compounds in a human tissue-on-a-chip model prior to clinical trials. Our​ proprietary, Vascularized Micro-Organ (VMO) platform is the first to contain a 3D, perfused network of living, dynamic human blood vessels that deliver nutrients and drugs directly to tissues just as in the body. Ask about our oncology models that incorporate multiple human tumor types within the vascularized tissue or our blood-brain barrier model for testing trans-barrier transport of drug compounds targeting the brain.

Blending technology and science, we develop instrumentation to improve outcomes. Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research. Speed is essential for furthering our understanding of biology, and we believe in reducing the time needed to acquire high-quality data and obtain clear, high-quality results. By making advanced technologies accessible, we allow researchers to focus on the science, not the tool. Our goal is to develop innovative products that accelerate basic research, drug discovery, and manufacturing to advance healthy outcomes. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach. We strive to make the drug discovery process more efficient, reducing the time and bandwidth needed to screen compounds. By pairing fast, easy to use hardware with advanced artificial intelligence analysis algorithms, we aim to transform the drug discovery pipeline, allowing customers to fail faster.

Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines.

Arizona Research Center was founded in 1997, to carry out reliable and meaningful clinical research for Valley residents. Since that time, over 650 clinical trials have been conducted. Our proven model, and combined years of experience, affords us the ability to provide our patients and sponsors with valuable expertise in numerous medical conditions. Our Investigators are frequently listed as lead authors of publications in medical journals, and often serve as consultants to such companies. Arizona Research Center represents an ongoing and growing network of over 100 Valley Physicians, including 50 Surgeons, and 10 Hospitals that enthusiastically support our research efforts. We take great pride in everything we do and have developed gratifying and lasting relationships with our Patients and Sponsors. Our staff includes 2 full time Principal Investigators, 1 part-time Principal Investigator, 6 Certified Clinical Research Coordinators, 4 Clinical Research Coordinators, and Research Assistants. In addition, we have a dedicated Regulatory Department offering 48-hour turnaround time, outstanding Quality Management, a committed Patient Recruiter, Marketing and Business Development, Contract Administrations, and Operations & Human Resources personnel.

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing for the pharmaceutical industry. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines. Whether you are a raw material supplier, equipment manufacturer, pharmaceutical manufacturer, pharmacy, or health-system we provide the testing needed to get your drug products ready for release. ARL's dedicated team oversees the entire process from understanding your goals to providing results and helping interpret the data. ARL Bio Pharma is an FDA registered and audited analytical laboratory and DEA licensed for Schedules I through V. The laboratory is ISO 17025:2017 accredited as applicable to our scope of accreditation. 17025:2017 accreditation independently demonstrates ARL's ability to not only comply with quality requirements, but to competently perform specified tests and activities.

Athens Research and Technology, Inc. (ART) is a dynamic life science company and recipient of the Globe Award as Georgia's 2022 Exporter of the Year. Since our founding over three decades ago, we continue to proudly support the life sciences industry in the advancement of essential medical diagnostics and therapies. ART is renowned for defining the industry standard for native protein purification. We specialize in producing natural human and animal proteins critical to academic research and manufacturing in the Clinical Diagnostic, Cell Culture Media, and Standards/Calibration industries. Our custom purification programs support our long-standing distinguished industry partners as well as our growing base of inspired customers. Since 1986, ART products have been sought after by prominent academic researchers and biotech companies for high-impact research published in Nature, Science, & Cell journals. ART proteins have been crucial for Alzheimer's, Cancer, Cardiac, Pulmonary, and Covid-19 research. Envisioned by local physicians and a university of Georgia researcher, ART was one of the first Life Science start-ups to launch from the University of Georgia incubator. Since our inception, we have served as a model for success to many subsequent companies. We are committed to People, Purpose, & Proteins. People are at the core of our belief system. Our culture continues to attract great talent, developing the next generation of industry-leading Protein Chemists. Purpose is ingrained in our being, keeping quality proteins at the forefront of research for the world's most complex medical challenges. Our purpose overflows into the Athens, GA, community as we ensure the health and strength of our neighbors and the growth of our local economy. Proteins are the core of our success. After 36 years, our company holds a breadth of knowledge of proteins and purification processes, allowing us to purify even the most complex and least abundant proteins in the human body.

Atom Bioworks is a startup company that specializes in DNA nanostructures.

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axiom's AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.

Beacon Clinical Research is a multi-specialty clinical research facility specializing in Phase I-IV clinical trials. In 2000, Beacon Clinical Research was established to offer patients the opportunity to enroll in clinical pharmaceutical trials. Participants are significant in contributing to the development of new innovative medications. Study participation potentially benefits the individual patient and contributes to the advancement of health care in our society.

Beaufort is a global CRO built around one purpose — helping life science companies improve and save lives through the rapid development and commercialization of innovative products. Our shared interest and commitment to your success drives our entire organization to deliver best-in-class clinical trial services, regulatory strategy and planning, data and business analytics, data management and statistics, and quality services. We are: ◈ MedTech Focused - Industry-leading expertise to streamline your clinical development. ◈ IVD Specialists - Two decades of extensive diagnostic experience. ◈ Results Oriented - Guided by efficient and adaptive clinical trial management. ◈ Partnership Driven - 94% of clients rate Beaufort higher than other CROs Our experience includes: ◈ 500+ Regulatory Submissions including 510(k)s, PMAs, IDEs and CE-Marks ◈ 4,000+ Clinical Study Sites Around the Globe ◈ 1,000+ Clinical Trials Across a Wide Variety of Indications and Testing Platforms ◈ 2,600+ Clinical Professionals in Over 50 Countries See how Beaufort CRO can accelerate your medical innovation -- and put our experience to work for you.

Purpose-built for organizations conducting clinical trials and observational studies, we leverage our AI-powered patient-matching platform and clinical expertise to optimize feasibility and speed up patient identification by extracting structured and unstructured data from electronic medical records (EMRs) that captures three times more trial criteria. Why: We believe sites are vital to the success of clinical trials. Empowering them to find the right patient for the right research at the right time is the focus of everything we do. What: We leverage our best-in-class technology and data expertise to detect more protocol-eligible candidates than traditional methods, so that site teams can focus on the parts of the job they actually love. How: We deliver an AI-powered software platform and support from clinical experts that enables our customers to find and match patients to available clinical research. With unbelievably fast and highly-accurate data extraction from electronic medical records (EMRs) we can capture three times more trial criteria - making trial participation more accessible and efficient.

Benchmark Research, an Avacare business, has a track record of safety and expertise, having conducted more than 1,000 trials since 1997 at clinics located in California, Louisiana and Texas. Benchmark's superior team of motivated and focused investigators offers clinical trials experience in a wide range of therapeutic areas. Our knowledgeable investigators enthusiastically embrace clinical research and the opportunities that new therapies bring to the marketplace and patients. Dedication and experience aside, our investigators are also highly trained in GCP and FDA regulations.

BioAgilytix is a biotechnology company that specializes in bioanalysis for the biopharmaceutical and life sciences industries.

At BioAI, we are developing world-leading machine learning technology to map the causal biology of disease, develop digital biomarkers, and identify novel drug targets, for the development of better medicine. BioAI’s PredictX Platform intakes your data and generates novel insights. PredictX is capable of ingesting a range of data types including: Digital Pathology, Multiomics, and Real-World Evidence. Using multimodal data and the most advanced AI methodologies, including In-silico phenotype projection and integrated deep learning, we can build predictive and prognostic models across a broad range of therapeutic areas. Founded by a group of friends who started by scribbling their ideas on a piece of paper, today we offer smart, innovative services to dozens of clients worldwide. Our team of experts has a proven track record in developing strategic partnerships with the Pharma industry and solving major challenges in R&D

BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).

BioGeometry is an AI-driven biotech dedicated to developing next-generation, programmable protein medicines. We aim to solve the high cost, long lead time, low success rate problems for traditional macromolecular theraputics through the combination of geometric deep learning, structural biology, immunology, and synthetic biology. We enjoy talents from renowned pharmaceutical companies, top-tier AI and bio labs worldwide.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients' needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

BIOQUAL, Inc. is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and has a long history of providing state-of-the-art facilities and trained, experienced research scientists, veterinarians and animal care personnel for clients involved in infectious disease investigations, cancer research, and a wide variety of other in vivo and in vitro studies.

For over 20 years, Biorasi has been to go-to CRO (Contract Research Organization) for small to midsized biopharma companies, optimizing speed-to-market solutions across global clinical trials in oncology, neurology, dermatology, and cell and gene therapy. Our #OneTeam of leaders and clinical study experts focus on the qualities necessary to succeed in today's clinical trial industry – flexibility, reliability, and transparency. It is Biorasi's mission to be a catalyst for growth, innovation, and evolution in the field of clinical research – moving the industry forward while improving results for our partners and outcomes for their patients. Our culture is based on our strong commitment to building true partnerships with our sponsors. We approach all of our trials with urgency, commitment, and resolve. Biorasi is able to directly support studies in the Americas, Europe, and APAC. We have received multiple accolades including placement in the INC 500 and 5000 list of fastest-growing companies in America, Frost and Sullivan's Entrepreneurial Company of the Year for the CRO Industry, and the CRO Leadership Award from Life Science Leader magazine.

We provide services in genomics, statistics, and information technology. Our services include Bayesian analysis, bioinformatics, biomarker development, biostatistics, data management, data pipelines, data science, epigenomics, genetics, genome-wide association, imputation, microarray analysis, multiomics, next-generation sequencing analysis, pharmacogenomics, polygenic risk scores, predictive modeling, project management, proteomics, reproducibility, software development, statistical computing, statistical genetics, and statistical programming. We also developed the Smokescreen® Genotyping Array, advancing research into addiction and treatment approaches. Our highly-skilled transdisciplinary team of experts, carefully assembled from leading research universities and industry, has been solving our clients' research challenges for almost two decades. Extensive experience with a wide range of cutting-edge methods and technologies means we can help ensure your project's success, and provide high-quality deliverables on time and within budget. Whether you have a critical issue, need help with every aspect of a new project—including coordinating complex projects—or only one part of an ongoing project, we can work with you to develop the optimal solution to meet your goals and objectives. Our team can be an integral part of the collaboration, and provide full-service support for all the stages of your research journey. We follow all U.S. Department of Health & Human Services standards for the security of electronic protected health information (HIPAA-compliant). We believe in reproducible, reusable, transparent, and extensible research, and do everything we can to put those values into practice. We are prepared to use our internal computing environment, cloud-computing environments, or client-provided environments, if preferred.

Biostate.AI is a startup founded in 2023 with the mission of developing generative AI for predictive omics analytics in the healthcare sector. They offer services such as RNA sequencing, DNA sequencing, image sequencing, image data analysis, and more. The company aims to lower costs and increase the utility of RNA sequencing for research and drug discovery.

We are a one-of-a-kind resource built for the future of life science research​. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries​ ISO-certified Biobanx biospecimen inventory ​ ACRP and CCRA-certified clinical research services​ CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow's therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.

Boston Clinical Trials (BCT) is a leading medical research center based in Boston, MA. BCT works with the top Pharmaceuticals on clinical studies in the areas of Dermatology, Gastroenterology, Internal Medicine, Neurology, Psychiatry, Sexual Dysfunction, and Urology. Our mission is to conduct safe and effective clinical trials to advance the development of new medications and therapies.

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.

CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites' commitment to real world solutions. Rely on us to confidently progress from site selection to study close-out and accelerate life-changing therapies. Get more value from your clinical trials with CenExel.

Analytical, Microbiological, Pharmaceutical, OTC, Contract Lab, Consulting for Analytical, FDA Deficiency, Water Testing , High Resolution GC-TOF-MS

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

ChemDiv, a fully Integrated Target-to-Market Contract Research Organization (CRO) headquartered in San Diego, CA USA. ChemDiv provides integrated drug discovery and early clinical development deliverables by extracting added value from potential therapeutic candidates via rapid, streamlined outcomes and effective use of capital. - 25 years experience and 2500 customers worldwide - Premium R&D CRO based in USA with global reach - Seasoned project managers - Extensive Academic partnerships - Flexible business models - Competitive pricing options - Industry's largest ever-greening stock compound inventory - Ongoing investments in novel proprietary chemistry and discovery platforms One of the oldest CROs in the industry, ChemDiv provides Integrated Discovery outSource™ solutions that cover the complete range of disciplines needed to bring new drugs for treatment of CNS, oncology, inflammation, metabolic and infectious diseases from target to candidate and through clinical Proof of Concept to the market. ChemDiv champions collaborative development models with co-investors to rescue under-exploited R&D assets for pharmaceutical and biotech partners. #pharma #biotech #chemistry #screening_Libraries #drug_discovery_services

Since 2005, the Chicago Research Center's dedicated team of qualified, board certified physicians, licensed clinicians, psychometricians and trained support staff have taken part in more than 750 clinical trials over the past 12 years. As an independent research center, CRC specializes in the pharmaceutical and biotechnology industries, focusing their studies in areas including psychiatric, sleep, and general medicine. Located in Portage Park, but serving all of Chicagoland, CRC takes the utmost care to ensure participants of their clinical trials have a safe and rewarding experience. The results of their efforts continue to exceed sponsor expectations for reliability, dependability, human protection, and overall performance. With a combined 25 years of expertise in the industry, Chicago Research Center continues to impact lives through novel developments and provides leadership and continuity to the research industry.

Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.

Clarity Genomics provides consulting services for microbiome-metabolome data insights in clinical research. Using our global network of specialists and regional cloud storage and computing, we provide expertise in collection and preparation of microbiome and metabolome samples, data processing and analysis. We work closely with our clients to offer biological insights that empower the development of new microbiome products and therapies. Partnerships with leading research institutions ensure that your project receives relevant information utilizing technologies and techniques on the forefront of innovation.

Clinical Investigation Specialists, Inc. (CIS), is an independent, premier Clinical Research Management Organization. CIS has conducted Phases I-IV clinical trials for pharmaceutical and biotechnology companies. CIS is committed to providing personalized attention and services by utilizing resources other companies cannot provide. We maintain a proactive pursuit of value added services to meet our clients' changing needs. Our extensive CIS/MD Network consists of the most qualified Board Certified physicians covering all major therapeutic areas. We are proud to break the mold by distinguishing ourselves as a clinical research management organization that is on the cutting edge of medicine. CIS offers not only services you may receive from a CRO & SMO, but also services encompassed by a hands on Research Management Organization. Sounds like a smart choice for companies looking for an efficient means to move their products through the pipeline with more personalized attention. There are many advantages when you choose CIS for your upcoming trials. Our experienced Investigators and Research Coordinators offer innovative ideas every step of the way to help you achieve your desired results.

Clinical Trial Network offers quality medical attention to the Houston area, while gathering data to generate industry-leading clinical research to pharmaceutical, bio-technology sponsors, and leading Contract Research Organizations.

Clinilabs Drug Development Corporation is a contract research organization (CRO) that provides clinical drug development services to industry. We are experts in CNS drug development. Clinilabs provides first-in-human through end of phase 3 services, with a global core laboratory. It is an alternative to large CROs providing a full spectrum of offerings to meet the needs of our customers world wide. Since 2000, Clinilabs has completed more than 675 clinical trials, and has worked for 15 of the top 20 pharma companies in the world, to contribute to 19 successful new drug applications (NDAs).

Clinion is a leading global clinical trial company renowned for its award-winning solutions that drive innovation and excellence in the field of clinical research. We implement cutting edge technologies like AI/ML and GenAI to accelerate clinical trials for better outcomes. Our unparalleled expertise empower pharmaceutical, biotechnology, and medical device companies to conduct clinical trials more efficiently and effectively. Join us in revolutionizing the future of clinical trials and making a lasting impact on global healthcare. Facebook : https://www.facebook.com/clinion Twitter : https://twitter.com/clinion YouTube : https://www.youtube.com/c/Clinion Instagram : https://www.instagram.com/clinion_ai/

ClinSmart is a contract research organization based in Bucks County, Pennsylvania. We offer personalized, comprehensive clinical development services with an experienced and dedicated staff. You can count on our team of industrial and academic professionals to manage key aspects of your upcoming trial. Our service offerings include: • Drug safety • Regulatory • IND preparation • Clinical strategy • Project management • Biostatistics & programming • Site management • Data management • Medical writing

Cloudbyz is focused on building cloud-based products and solutions for life sciences customers, and help them innovate drug development and research to bring therapies faster to market which improve patient health and saves lives. Our innovative digital solutions for Pharmaceuticals, Contract Research Organizations (CRO) and Medical Devices companies helps to digitize research, drug and device development and commercialization. Our suite of products include: 1. Cloudbyz CTMS 2. Cloudbyz CTBM 3. Cloudbyz eTMF 4. Cloudbyz EDC, ePRO & eCOA 5. Patient Recruitment 6. Cloudbyz Safety & PV 7. ClinicalWave.ai (AI based platform for Life sciences organizations) Cloudbyz CTMS, eTMF, EDC, and Safety & Pharmacovigilance are built 100% native on Salesforce cloud platform for sponsors, clinical research organizations (CRO), and Clinical Sites. Cloudbyz Clinical Research Solutions are flexible and scalable to enable to manage and collaboration on clinical trial operations while the intuitive, straightforward design allows rapid deployment with a very intuitive and easy-to-use cloud-based solution. Cloudbyz ITPM offers 360° view and real-time visibility across IT planning, execution, and operations and helps organizations to achieve agility, velocity, innovation, and collaboration across IT and business. Cloudbyz ITPM helps CIO, PMO, and IT leaders to visualize the IT landscape, capability mapping, investment, and operational health in real-time and better align IT initiatives with business.

Since 1996, CNS Healthcare has safely and effectively managed thousands of clinical trials in Orlando, FL; Jacksonville, FL; and Memphis, TN. Our work has resulted in the collection of information about pharmacological developments that have given way to some of the most widely prescribed medicines today. Our work continues on today, with more staff and larger facilities, in order to exceed the expectations of our patients and industry partners.

Conceivable has developed the world’s first fully automated IVF lab. Our end-to-end reinvention of today’s largely manual, artisanal labs delivers new levels of precision, quality, and scalability. Simultaneously, Conceivable brings the innovation of modern cell therapies to IVF. We are already exceeding the clinical benchmarks of today’s best IVF labs. Worldwide 95% of the infertile population–and 80% in the United States–don’t have access to IVF. Conceivable exists to change this. By automating the IVF lab we will vastly broaden the availability of this Nobel Prize winning therapy, improve results, and meet the demands of millions of infertile people wishing to achieve the dream of becoming parents.

Confidence Pharmaceutical Research (CPR) is a dynamic force in the pharmaceutical industry, driven by a vision to revolutionize drug development. With a dedicated team of over 100 passionate professionals, Confidence combines the global reach and full-service capabilities of a large Contract Research Organization (CRO) with the agility and client-centric focus of a boutique firm. Our lean management approach ensures cost-effectiveness without compromising on quality, making us an ideal partner for organizations seeking innovative solutions in drug discovery and clinical research.

Corgenix is part of the SEBIA Group. Located outside of Denver, Colorado, USA, Corgenix is a CAP/CLIA accredited laboratory specializing in clinical studies, clinical trial management and physician-ordered patient testing. Corgenix is also a experienced in CDMO—Contract Development and Manufacturing Organization. Corgenix is a highly capable strategic partner with history of success; our main client groups are Biotech companies, Pharmaceutical industry, Cancer Centers, and Academic laboratories. Strategic collaborations have covered all aspects of the IVD process –development, quality control, regulatory compliance, manufacturing (We are ISO-13485:2016, an FDA registered facility and GMP compliant), warehousing, distribution, product support, and commercialization. . Whether you need support for research, clinical trial testing or contract clinical testing services, we are here to serve. Above all, we believe in clear communication and transparency. We take a cross-functional team approach to our projects, fully engaging with our clients throughout the project. What do you need? Please contact us to see how we can support your business strategy!

CosmosID provides award-winning, end-to-end microbiome solutions. They offer NGS, Metabolomics, Bioinformatics, as well as the world's most advanced microbiome analysis software, CosmosID-HUB: Microbiome. The HUB relies on validated databases and algorithms specifically designed for maximum sensitivity, precision and lowest false positive rates. Unlike other solutions, CosmosID delivers strain-level results – we understand that the biologically informative and actionable unit in microbiology is not a genus or species, but ultimately a strain and its unique genetic and metabolic properties. CosmosID was founded in 2008 by Dr. Rita Colwell, former director of the National Science Foundation and currently Distinguished University Professor at the University of Maryland and Johns Hopkins University Bloomberg School of Public Health. To learn more please visit www.cosmosid.com.

Courante Oncology is a full-service clinical research provider specializing in oncology product development. We offer a wide range of clinical trial management and support services to the pharmaceutical and medical device industries, including project management, clinical site monitoring, quality assurance, and medical writing servies. We believe the challenges of oncology clinical trials require a research team that is uniquely experienced and trained. Our strength lies in our collective experience and our ability to adapt to and meet our clients' specific research needs.

Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management. Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye resulting in rapid patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials. We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data. Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.

CSSi LifeSciences™ Drug & Medical Device Commercialization & Medical Device CRO Our goal is to ensure a successful and expeditious pathway to commercialization for our clients’ drugs and medical devices by providing insight-driven analysis that saves time, development costs, and resources. We enable faster, more informed decision making to increase commercial success, while reducing the risk of late-stage failures and post-authorization action. Unparalleled Success from Discovery to Commercialization • Commercialized over 500 new drugs, biologics, medical devices, and in-vitro diagnostics • Over 250 medical device 510(k) Class 1-3 submissions with 100% success. • Extensive Orphan, “First in Class,” and “First In” Indication success. • Reduced time to approval by over 600 days. • Over 100 NDA, ANDA and BLA submissions, with 96% success. • Greater than 60 EMA CHMP Marketing Authorizations. • SmartStudyTM design and feasibility assessments enhanced study efficiency and success and reduced protocol amendments by over 50%. CSSi LifeSciences Medical Device CRO has experience navigating regulations in over 100 countries. Often companies struggle with the pathways for a medical device from design to commercialization because of the ambiguity and complexity of the process. Regulations and requirements change frequently and vary by notifying bodies, country, level of risk (i.e., Class 1-3), specific product claims, and intended use. Our diverse team has many years of medical device commercialization experience, with the knowledge that goes beyond published guidance, documents and initiatives. CSSi LifeSciences Medical Device CRO aims to impact the timeline of regulatory clearance and increase profitability.

CureMatch is a leader in AI-based precision medicine, digital decision support solutions that support cancer treatment. Created to empower oncologists with world-class research and sophisticated AI algorithms, the CureMatch Decision Support System assists the doctor with understanding therapeutic options that are personalized to the unique molecular profile of the individual patient's tumor.

Deep 6 AI is a clinical trials software company based in Pasadena, California, founded in 2016. The company focuses on accelerating patient recruitment and enhancing clinical research through AI-powered analysis of real-world clinical data. In March 2025, Deep 6 AI was acquired by Tempus, further integrating its capabilities into Tempus' healthcare ecosystem. The company specializes in AI-powered patient matching, which analyzes both structured and unstructured electronic medical record data to identify eligible patients for clinical trials. Its platform connects healthcare organizations, researchers, and life sciences companies, streamlining trial workflows. Deep 6 AI also generates real-world evidence to support rapid clinical trial feasibility analysis and data-driven protocol design, utilizing natural language processing and machine learning to process data from over 25 major healthcare organizations.

DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicine.

Mission Diablo Clinical Research is committed to advancing health through medical research and community service. History Diablo Clinical Research, established by Dr. Weinstein in 1995, has conducted over 600 studies with thousands of patients. Today our database is comprised of over 12,000 patients who have either completed a study with us, are currently enrolled in a study, or have expressed interest in future clinical study participation. Our Founder and Medical Director Richard L. Weinstein, MD a board certified endocrinologist and internist has practiced medicine in the San Francisco Bay Area for 30 years. In 2005 Leonard Chuck, PhD, MD and a practicing internist in our local community for over 20 years joined Diablo Clinical Research as an Investigator. In 2007 Mark Christiansen, MD, who practiced and conducted research in the community for over 17 years, also joined Diablo Clinical Research as an Investigator. Both Dr. Chuck and Dr. Christiansen became Co-Medical Directors of our facility in 2008. Diablo Clinical Research specializes in clinical research. We have been working in our Walnut Creek location for over 17 years. We have 6 MDs on staff with specialties in endocrinology, internal medicine, cardiology, and neurology.

DM Clinical is a clinical trial network that specializes in connecting patients with trusted physicians for research studies.

DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in neurology/CNS (including spinal cord injury), oncology, ophthalmology, infectious disease/vaccines, and rare disease Phase I-IV clinical programs. DP Clinical provides a full complement of clinical trial services to pharmaceutical, biotech, and medical device companies including trial management, monitoring, data management, biostatistics, regulatory, safety monitoring and reporting, and medical writing. Since 1994, we have worked for clients of all sizes — small to large pharmaceutical and biotech companies, academic research institutions, and government sponsors. DP Clinical provides integrated trial solutions as well as specific service components based on sponsor need. Our comprehensive services include: • Project management • Clinical trial monitoring • Data management • Biostatistics • Pharmacovigilance and safety • Regulatory affairs • Quality assurance • Medical writing

DSG, Inc. is a leading global eClinical provider with a fully unified suite of innovative technology solutions and data management services for the global clinical research community. DSG's eClinical software platform provides competitive advantage that is cost-effective with on-time project delivery. DSG solutions have been used in thousands of clinical trials around the globe with our award-winning eCaseLink™ platform and eCaseLink Designer for enterprise licensing. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Trial Supply Management system with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com

The Duke University Clinical Laboratoriesemploy a wide range of practices; from high-throughput, highly automated testing in their hematology, chemistry and immunoassay laboratories, to specialized mass spectrometry and molecular based testing in many of their subspecialty labs, to direct patient care bytransfusion services physicians. In total last year, their 850 clinical laboratorians deliveredover 10million resultsto support the care of the many hundreds of thousands of patients who came to Duke.In additional to supporting the clinical mission of DUHS, theyalso support the other two missions of theiracademic health care system: teaching and research.

EDDA Technology, Inc. is an innovative leader in the rapidly growing field of imaging-guided cancer treatment. By adopting a fully quantitative, real-time interactive approach to imaging analysis, simulation and guidance, our next generation computer-assisted radiology and surgery solutions go well beyond advanced 3D image visualization. The award-winning IQQA® platform supports a patient-specific, disease-targeted, and multi-disciplinary approach to cancer treatment. With exceptional ease-of-use and clinical versatility, it facilitates efficiency and precision in treatment planning, guidance, monitoring, and follow-up. The IQQA® platform provides targeted solutions to assist physicians in advanced clinical applications including: fast 3D quantitative analysis and visualization, highly automated volumetric organ/lesion segmentation & quantification, pre– & post–operative assessment, treatment planning & simulation, procedural guidance and monitoring, and Computer-Aided Detection (CAD).

Elephas is a biopharmaceutical company focused on developing an oncology imaging diagnostics platform to predict response to immunotherapy using the latest advances in metabolic and ex-vivo technology. The company is also building an instrument platform that will inform how clinicians treat cancer patients by interrogating live human tumors ex vivo.

ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics.

EvolutionaryScale is a biotech startup focused on AI research in the field of biology. The company has developed a database of over 2 billion protein sequences to train its AI model, offering technology that can provide insights into biological processes. EvolutionaryScale has raised significant funding, including a $142 million seed round, and is known for its ESM3 Generative AI Model for biology.

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Frenova advances clinical trials that can change lives. As a dedicated site management organization, Frenova delivers a global network of research sites, a diverse patient population, and long-standing expertise to get your trial up and running quickly. Site investigators work at the intersection of research and patient care. Through our relationship with Fresenius Medical Care's global dialysis clinics and partner nephrology practices, we can uniquely reach potentially hundreds of thousands of ESKD and CKD patients worldwide for renal clinical trials and studies of adjacent conditions. Because we have access to one of nephrology's largest longitudinal patient databases, we can also offer data analytics and licensing services to support you during the planning and development stages of your study.

Frontier Scientific Solutions (FSS) is a contract service organization (CSO) which supports the life science industry by offering cGMP temperature-controlled storage, distribution, and logistic services. Drug development and commercialization require continuous temperature monitoring and control. Frontier's diverse offerings protect product integrity throughout the pharmaceutical supply chain. FSSs' validated software, cGMP storage and drug distribution facility, industry expertise and stringent quality standards support this objective throughout packaging, storage and distribution.

Our mission is to develop flexible and affordable diagnostics and therapeutics that improve the everyday lives of those around us. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike. - Our Products & Services - Fulgent Genetics https://www.fulgentgenetics.com/ Fulgent Oncology https://fulgentoncology.com/ Fulgent BioPharma https://biopharma.fulgent.com/ Picture Genetics https://picturegenetics.com/ HelioLiver https://www.helioliver.com/ Fulgent is a CLIA-certified and CAP-accredited laboratory. _____________ NASDAQ: FLGT

We are building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups. Core to our mission is building trust with the communities we serve and long term partnerships with communities, researchers, clinicians, and most of all patients and their families. This is your biobank and for the benefit of all. If we build it, we can decide how the data are used. And no one is going to do it for us, so let’s roll up our sleeves and “time to build.” Join us! Este biobanco es tuyo y para todo el continente porque si lo construimos juntos podemos decidir cómo se usan los datos y con que fines. Nadie lo va a hacer por nosotros así que bienvenido a nuestro esfuerzo. Unete!

Galenos Research is a comprehensive clinical research center in Dallas, TX, working in conjunction with the office of Rafael Canadas, M.D. to conduct Phase II-IV Clinical Trials.

Genemarkers is a Kalamazoo, Michigan-based contract services laboratory specializing in genomics research and molecular testing services, with a primary focus on consumer products, dermatology, skin-related research and therapeutics.. Founded in 2008 by former professor and neuroscientist Dr. Anna Langerveld, Genemarkers has proven its expertise through collaborations with cosmetic, pharmaceutical, and academic research institutions over the years. Taking pride in providing actionable, high quality data and customer service, Genemarkers' CLIA-certified and CAP-accredited laboratory has the ability to support a wide range of projects throughout discovery and development including advanced cellular models/exposures (e.g., dermal/transdermal, hepatic/extrahepatic, neuronal and bronchial/inhalation) and next generation bioinformatics and computational modeling.

Molecular Pathology Laboratory Network (MPLN) has been at the forefront of laboratory medicine since its inception in 1989 and inspired the genesis of women's health testing using molecular diagnostics and technology. For decades, MPLN has continued to lead the way in specialty testing with an emphasis on women's health and oncology. MPLN strives to be the best client experience in laboratory medicine by bringing you comprehensive specialty testing, informatics using the latest digital applications, and unparalleled customer service. Our history is rich and rooted in our foundation of providing the very best in patient care, by exploring, developing, and delivering innovative solutions and technologies that elevate our field. Providing an expanding menu of molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization and cytogenetic testing, MPLN is dedicated to providing superior diagnostic services to our clients in pathology groups, hospitals, medical laboratories and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide: · High-quality, timely results · Cost-effective testing strategies · Personalized consultative testing services from Board Certified Hematopathologists · Responsive and professional customer service

Automate and scale your participant recruitment and engagement with the Grove AI Assistant and PRM™. Our AI assistant is available 24/7 and adapts to every trial, ensuring the right participants are connected to the best clinical trials.

H&A Scientific, Inc. is a scientific software development firm specializing in pharmaceutical industry support. We develop, validate, and market quality computing systems for scientific data acquisition, processing, and data management. We have been creating programs for the laboratory since 1992. Our products have been designed under our Quality System to adhere to the current GAMP guidelines. We develop Quality Software products based on the needs of pharmaceutical companies subject to the constraints and compliance of the Food and Drug Administration (FDA). Our flagship product, SLIM, is a commercial off-the-shelf solution for total management of a company's drug stability program. Learn more about us: https://www.youtube.com/watch?v=_GZ9PQ9d4dI

Established in 1996 and located along Route 128 in MA, HAI Laboratories, Inc. is the only American manufacturer of clinical, eye bank and laboratory specular microscopes in operation today. We are also known for our advanced software systems for image processing and analysis, digital video slit lamps and high quality ophthalmic microsurgical instruments.

ICON works to accelerate the development of live-saving drugs and devices by providing a wide range of consulting, development, and commercialization services.

Imaging Endpoints is a leading oncology-focused imaging contract research organization (iCRO) dedicated to enhancing clinical trial outcomes through advanced medical imaging. With a mission to "Connect Imaging to the Cure," the company operates 8 offices across 6 countries and employs over 40 in-house radiologists and nuclear medicine physicians, including experts in oncology imaging. Their services cover the entire spectrum of oncology trials, from translational research to Phase 3 trials, ensuring regulatory compliance and customized imaging solutions. The company offers comprehensive imaging support, including protocol development, site qualification, image acquisition, and advanced imaging analysis. Their proprietary Imaging Clinical Trial Management System (iCTMS) facilitates real-time data tracking, while the RaDAR program accelerates drug development timelines. Imaging Endpoints collaborates with a range of biopharma companies, supporting pivotal oncology trials that lead to regulatory approvals.

Inocras is a company for whole genome sequencing, providing a comprehensive view of a patient's entire genetic profile through WGS analysis and interpretation. Focusing on cancer and rare diseases, we aspire to fundamentally change how the world treats genetically driven diseases with an unsurpassed WGS databank and an integrated platform for generating, collecting, and analyzing genomic data.

Clinical Research

Inteliquet, an IQVIA business, Inteliquet is a leading provider of innovative technology and comprehensive support services for cancer clinical researchers. We bridge sponsors, patients and cancer centers nationwide for the ultimate purpose of increasing patient access to cancer trial treatment options. From trial selection to patient matching, Inteliquet enables a streamlined and more accurate journey to patient enrollment. To learn more about Inteliquet, visit https://inteliquet.com/

Intrinsic LifeSciences LLC provides superior, innovative & patent-protected research test kits and certified diagnostics & clinical research CLIA services for hepcidin and erythroferrone (ERFE), the key indicators of anemia, inflammation and pregnancy disorders. Our CAP accredited clinical lab, IntrinsicDx™, offers the Intrinsic Hepcidin IDx™ Test service. We also provide RUO immunoassay testing for other related biomarkers. To learn more visit www.intrinsicdx.com, www.intrinsiclifesciences.com.

IQVIA applies data science to the continuous advancement of human science to make health care decisions more precise, relevant, and even creative.

Irvine Clinical Research is an independent, physician investigator-owned clinic specializing in Phase 2-3 sponsored clinical trials in neurology and psychiatry. We have a demonstrated history of enrolling subjects quickly, producing quality data to Sponsors, and ensuring the highest standard of patient care. Our largest areas of study are in Mild Cognitive Impairment/Early Alzheimer's Disease and Depression therapeutic trials. According to publicly available CMS data, Irvine Clinical Research is the top independent site in Alzheimer's Disease clinical trials in the state of California, as measured by industry research grants.

iuvo BioScience is a contract research organization serving the pharmaceutical and medical device industries. Our services encompass pre-clinical research, clinical research and consulting services. With a focus on safety and biocompatibility, iuvo provides assistance through the full product development life cycle, from research to release, including ISO 10993:2018 testing as well as testing programs and advisory services to support regulatory submissions. We have an AAALAC-accredited vivarium and offer full service, GLP-compliant toxicology testing, as well as microbiology and analytical chemistry testing laboratories. We are certified to ISO 13485:2016 and accredited to ISO 17025:2017 quality system standards. We bring decades of experience supporting healthcare and medtech companies of all sizes from around the world, and we work closely with our customers to deliver exquisite science, reliably and on time. Come to us with a specific test, a full program you need managed, or even a research question you need help answering. We are your Partner Research Organization.

Jeeva Clinical Trials Inc. specializes in decentralized clinical trial solutions, offering a unified SaaS platform that enhances global patient engagement and streamlines trial operations. The company utilizes AI-powered tools and modular technology to support efficient trial management, allowing sponsors and medical centers to conduct studies under a single login. Their services include decentralized and hybrid trial solutions, patient recruitment and retention tools, and comprehensive clinical data management. Jeeva's platform features a next-generation Clinical Trial Management System (CTMS) for real-time oversight and protocol adjustments. The company prioritizes security and compliance, adhering to HIPAA, GDPR, and other regulatory standards. Jeeva has successfully implemented its solutions in oncology trials, achieving significant improvements in patient enrollment and data accuracy. They also support academic research, reducing costs and administrative burdens for campus-based studies. With a focus on scalability and workflow standardization, Jeeva provides a patient-centric approach to modern clinical trials.

Kamat Phamatech LLC is a privately held technology-based pharmaceutical company located in Central New Jersey. We specialize in the development, manufacturing, and approval of novel parenteral and enteral products and processes, particularly in the areas of new chemical and biological entities for treatments of various indications.

L7 Informatics provides a unified data and process platform (L7|ESP™) to streamline and optimize manufacturing, laboratory, and business processes across life sciences and healthcare value chains. The L7 Informatics' Unified Platform L7|ESP, with its Workflow Orchestration and Data Contextualization, meets the organizational needs of any life science organization digitalizing their data and laboratory processes, of which the result is maximized total ROI (return of investment), increased utilization and efficiency, and decreased overall cost. L7|ESP captures routine information in smaller labs, while also driving sophisticated wet and dry laboratory processes across an enterprise organization which requires data and analytics strategies that support LotF (lab of the future). The L7|ESP platform integrates all common data information management systems, including LIMS, Notebooks, and MES, but also other resources such as instrument connectors, sample registration, location, receipt accessioning, logistics, scheduling, inventory, environment monitoring, stability testing, custody of chain, and data analytics. L7|ESP is built by scientists for the life sciences community - relentlessly focusing on serving our customers in research, pharma, and diagnostics with the overall goal of better patient outcome. L7 Informatics is supporting customers around the globe that are tackling some of the most challenging and exciting opportunities in healthcare.

Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.

Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records. Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations.To date, Lindus Health has delivered clinical trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp.

LotusCR.com is a clinical research company specializing in Phase 1-3 trials for pharmaceuticals and healthcare products, with a focus on pain management, opioid-related conditions, and hospital-based populations.

MakroCare is expert Regulatory Consulting and Clinical Services partner for pharmaceutical, biotechnology and medical device industries. Our global/regional teams and fit-for-purpose costing models to your development strategy, regulatory management, clinical research, medical/scientific support and quality assurance areas. MakroCare has operations and presence in US, UK, EU, and Asia.

Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with clinical information incorporate all new discoveries in treatment plans.

The mission of the Medical College of Wisconsin is to be a national leader in the education and development of the next generation of physicians and scientists; to discover and translate new knowledge in the biomedical sciences; to provide cutting-edge, interdisciplinary and compassionate clinical care of the highest quality; to improve the health of the communities we serve. Founded in 1893 as the Wisconsin College of Physicians and Surgeons. Formerly associated with Marquette University.

MED Institute accelerate product development. MED Institute is dedicated to bringing new medical device products to market that are safe and effective for patients. From concept to commercialization, our team has the knowledge and experience to guide your products through the complex steps required for market approval.

Marc Clark is a medical research company that focuses on conducting clinical trials and providing resources for clinical trial volunteers.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.

At Medrio, we're fueled by an ambitious vision: to improve 100 million lives by enabling secure, reliable, and efficient clinical trials. Since 2005, we have cultivated a thriving network of individuals who share a common goal of making a positive impact - including our dedicated team of Medrians, valued customers, and trusted partners. Our eClinical solutions are flexible and configurable to meet the needs of any clinical trial - from traditional to fully decentralized. Our solutions are easy to learn, easy to use, scalable and connected through one unified platform, providing unmatched efficiency, reliability, clarity and sophistication. As an employer, our core values are rooted in a customer-first approach, an A-player mindset, and a sprinkle of quirkiness to keep things fun and interesting. We are dedicated to powering the potential of clinical research - and we invite you to be a part of our mission. Visit our website to learn more, request a demo, or apply to join our team.

Mendel AI is the only clinical AI platform that performs clinical reasoning to supercharge clinical data workflows. Powered by coupling large language models with a clinical Hypergraph, Mendel's AI copilots, known as Hypercubes, offer clinically trustworthy and explainable insights, streamlining tasks like cohort building, chart review, and data discovery. Mendel's solutions cater to biopharma, providers, and diagnostics, integrating seamlessly with existing tools and delivering proven results We strive for excellency, to be authentic and original, and to make a difference by greeting our challenges head on. Please visit our website, mendel.ai, to learn more about our company, goals, and values.

We bring together families, healthcare providers, and researchers to improve the quality of life for current and future patients. Our mission is to advance scientific and medical innovation through comprehensive patient-centric clinical research, in collaboration with our sponsors and providers. The Accel Research Sites Network offers leading sponsors, clinical research organizations and healthcare providers the ability to execute multi-phase clinical research studies. With a focus on precision and speed, our facilities are built for flexible, results-focused studies, able to be set up and executed on limited timelines. With decades of experience in the healthcare innovation space, you'll trust that every study, every patient, every outcome will be meticulously managed - with evidenced based results.

Micro Systems Engineering, Inc. (MSEI), with its main office in Lake Oswego, Oregon, is is a pioneer in developing innovative implantable medical device technologies and devices that save and enhance the quality of life for millions of patients across the globe. With more than 40 years of experience in design and manufacturing active implantable medical devices, our continuing success is based on our company's core values – innovation, quality, reliability, integrity, teamwork, and undisputed expertise – thus enabling us to inspire confidence and trust in physicians and patients worldwide. MSEI has two main divisions, Operations and System Design & Development. With over 400 technical staff including physicists, electrical, software, biomedical and materials engineers, MSEI employs an elite team of the brightest minds in the medical technology industry. The Operations division is a specialist in medical microelectronics manufacturing including development, design, testing, supply chain and system integration for medical technology, in particular for active implants in the area of CRM (cardiac rhythm management) and other medical applications. The Operations division is dedicated to the innovative design and quality construction of electronic modules used in implantable medical devices. System Design & Development is the innovation center for next generation class III active implants. This includes full system design, clinical research, hardware and software, as well as the design and test of application-specific integrated circuits (ASICs). The resulting products deliver life-saving therapies to patients accurately and reliably across the globe.

MCRC in Dayton, Ohio is a psychiatric medication research center specializing in medical research studies for a range of mental health disorders.

Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company's patented Fully Enzymatic Synthesis (or FES™), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of Molecular Assemblies, Inc.

Mountain View Clinical Research, Inc. - clinical trial research site with a focus on neurology, psychiatry, multiple sclerosis, internal medicine and psychedelic IP.

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client's industry experience, integrating its seven business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, due diligence and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA's integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, London, England, Winterthur, Switzerland, Eschborn, Germany and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.

Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.

Neuphoria Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Burlington, Massachusetts. Formerly known as Bionomics Limited, the company focuses on developing innovative therapies for neuropsychiatric disorders and cancers. Neuphoria was incorporated in 1996 and rebranded in December 2024. The company's lead product candidate, BNC210, is a selective negative allosteric modulator aimed at treating social anxiety disorder and post-traumatic stress disorder (PTSD). BNC210 is currently in Phase 3 and Phase 2b clinical trials, respectively. Other products in development include BNC101, a monoclonal antibody for cancer stem cells, and BNC105, which targets refractory colorectal cancer and chronic lymphocytic leukemia. Neuphoria is also exploring treatments for cognitive deficits in schizophrenia and autism spectrum disorders, as well as chronic pain management without opioid addiction. The company has partnered with Merck & Co., Inc. to develop therapies for cognitive dysfunction related to Alzheimer's disease and other central nervous system conditions.

North Carolina Clinical Research (NCCR) is an independent, multi-therapeutic outpatient clinical research site located in Raleigh, North Carolina. NCCR has conducted Phase I, II, III and IV clinical trials in both children and adults since 1986. We have completed over 530 studies in a variety of therapeutic areas for many different pharmaceutical companies and Clinical Research Organizations (CROs). NCCR is dedicated 100% to Clinical Research. We have a dedicated staff that makes our facility stand out above the rest. Our hardworking, passionate, and friendly crew makes studies placed at NCCR a positive experience for both the sponsor and the patient. Supporting our principal investigators in the completion of each study is a clinical research staff of more than 18 professionals including Sub-Investigators, Site Manager, Subject Recruiter, Regulatory Administrator, Clinical Research Coordinator, and Office Coordinator. Our team has over 225 combined years of Clinical Research experience. Our facility is located across the street from a major medical center, and we have access to a metropolitan population exceeding one million. We are also located near three major universities: North Carolina State, Duke, and UNC-Chapel Hill. Our facility includes a fully equipped lab, secured storage for ambient and refrigerated study drug, a patient lounge area for extended days, and overnight facilities with showers and individual sleep areas.

With over 20 years of expertise, NorthEast BioAnalytical Laboratories LLC, also known as NorthEast BioLab, specializes in providing top-notch GLP and clinical bioanalytical services. We are proud to be trusted partners to hundreds of industry sponsors and renowned investigators in the biotechnology sector. We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR). With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc. Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech. With our vast experience and technical expertise, we deliver exceptional preclinical study and clinical assay development services as a Contract Research Organization (CRO). At NorthEast BioLab, we prioritize top quality and industry-leading turnaround time while offering highly competitive pricing. Our team is dedicated to helping you meet the stringent timelines of various milestones throughout your drug development life-cycle. SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay development, validation, and sample analysis!

Supporting biotech companies from innovation to impact. Specialized clinical development solutions with dedicated teams. IQVIA Biotech is a CRO strategic problem-solver with therapeutic expertise.

BTC Network is a provider of business development and site identification services.

N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors. The N-Power Platform consists of: - The real-time Kaleido™ Registry, conducted with patient consent, that defines standardized data collection at the point of care and is malleable to partner needs, - A technology solution that enables data collection and analysis, and - Embedded on-site and virtual staff who support delivery of routine care, implement standardized, registry protocol-defined data collection and augment site staff in clinical research. By partnering with oncologists, research staff and patients in unlocking the full potential of every patient's data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.

Founded in 1831, NYU is one of the world's foremost research universities and is a member of the selective Association of American Universities. The first Global Network University, NYU has degree-granting university campuses in New York and Abu Dhabi, and has announced a third in Shanghai; has a dozen other global academic sites, including London, Paris, Florence, Tel Aviv, Buenos Aires, and Accra; and sends more students to study abroad than any other U.S. college or university. Through its numerous schools and colleges, NYU conducts research and provides education in the arts and sciences, law, medicine, business, dentistry, education, nursing, the cinematic and performing arts, music and studio arts, public administration, social work, and continuing and professional studies, among other areas.

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF’s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.

Orange Grove Bio was established with a clear vision: to bridge the gap between promising research programs and the successful development and commercialization of transformative therapies. Our company is driven by the recognition of the disparity in venture capital investment across different regions of the United States, often resulting in groundbreaking discoveries going unexplored and potentially life-changing treatments failing to reach the patients who need them most. Based in Cincinnati, we strategically partner with prominent institutions and researchers across the Midwest, Southeast, and Mid-Atlantic regions. By fostering strong partnerships built on a shared commitment to innovation, our aim is to ensure that discoveries from these regions translate into life-changing treatments for patients, unlocking the full potential of the most promising research programs.

OurCEL Solutions is Blood Assurance's cell therapy and research division.

At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our founders invented a new way to study the synthesis and regulation of DNA, RNA, and proteins. Driven by a desire to advance human health, we’re harnessing advances in biochemistry, optics, nanofabrication, and more. We are passionate about developing products that empower scientists to explore the full spectrum of genetic variation in any organism — from unraveling the mystery of rare diseases to improving the world’s food supply. With world-class service and support, we keep your research progressing so you can focus on finding answers. We encourage you to see the whole picture — and consider us the partner you trust to see it too.

Pace® Science and Technology Company makes the world a safer, healthier place. We partner with clients to provide the service, science, and laboratory data needed to make critical decisions that benefit us all. Through a nationwide laboratory network, Pace® advances the science of businesses, industries, consulting firms, government agencies, and others. ANALYTICAL SERVICES Pace® Analytical Services is a division of Pace® Science and Technology, providing local testing and analytical services backed by a large, national laboratory and service center network. Through in-lab, mobile, and emergency onsite containment and regulatory services, we ensure our air, water, soil, and more are safe for our communities and lives. LIFE SCIENCES Pace® Life Sciences is a division of Pace® Science and Technology committed to advancing the science of the pharmaceutical and biopharmaceutical industry by providing full-service CDMO/CRO capabilities and professional services for in-house labs through a nationwide network of service centers, manufacturing sites, and FDA-registered laboratories. COMMITMENT We believe the work our customers do is important to improving our communities and lives and are committed to supporting them through strong partnerships, delivering upon expectations, and providing exceptional customer service.

At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our founders invented a new way to study the synthesis and regulation of DNA, RNA, and proteins. Driven by a desire to advance human health, we’re harnessing advances in biochemistry, optics, nanofabrication, and more. We are passionate about developing products that empower scientists to explore the full spectrum of genetic variation in any organism — from unraveling the mystery of rare diseases to improving the world’s food supply. With world-class service and support, we keep your research progressing so you can focus on finding answers. We encourage you to see the whole picture — and consider us the partner you trust to see it too.

PanAmerican Clinical Research collaborates with pharmaceutical, biotechnology, and CROs to improve global public health through new drug, medical device, and diagnostics research. Founded in 2016, PanAmerican is located in Mexico and Texas, and has been a leader in clinical research. Using a patient-centric and community-based approach, PanAmerican excels in clinical research across numerous therapeutic areas and vaccine studies. PanAmerican's Passion: Community Focus: PanAmerican doctors and staff partner with local communities in Mexico and Texas, where significant disparities in healthcare exist. Clinical research is presented as a care option for the benefit of patients within these communities. Patient Focus: Patients are at the heart of everything we do. Patient centricity drives PanAmerican to understand the patient journey in all clinical studies. Understanding how a protocol impacts the patient journey is a priority. PanAmerican's doctor's and staff will often go to the patient's home when traveling to the site is not an option. Benefits of working with PanAmerican: - All staff is fluent in English and Spanish - PI's and study coordinators are physicians - Rapid turnaround of feasibility requests - Fast start up - Central contracting - Expansive database of participants in all therapeutic areas and vaccines - Quality data - Rapid turnaround of budget negotiations PanAmerican delivers results while providing health services and education to underserved populations, driving quality research outcomes, and building healthier communities.

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic's SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

PhaseV is leveraging cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop execution, in order to improve trial success rate while maximizing resource and time efficiency. Our novel methodology and advanced technology also enable the detection of hidden signals in data while analyzing clinical trial results and extracting actionable insights.

Phenome Health is a research organization dedicated to preventing disease and taking the guesswork out of healthcare. We are driving a revolution by moving past the disease-focused “find it and fix it” era to wellness and prevention that enables all of us to live longer and healthier lives.

Phesi has the industry’s most comprehensive and dynamic clinical trials database and predictive analytics tools to help trial sponsors make quick and informed decisions to expedite drug development. Our distinguished team works side-by-side with its clients to analyze data, answer questions, and offer informed solutions to benefit study sponsors, investigators, and ultimately patients. Phesi has been applying its innovative technology and deep expertise to help life sciences companies for over 10 years. Our experts work with study sponsors to drive solutions from clinical development planning through trial implementation to optimize protocol designs, select the best investigator sites, shorten enrollment cycle times, select and manage CROs, and much more.

The Pioneer Valley Life Sciences institute (PVLSI) was formed in 2002 as a partnership between the University of Massachusetts Amherst and Baystate Medical Center.It is an independent 501(c)(3) nonprofit organization dedicated to biomedical research.Its mission is to develop innovative approaches to diagnose, monitor and treat disease.

PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.

Precision Trials is a network of practicing physicians comprised of investigators and research professionals dedicated to enriching the lives of furture generations through a qualitatively superior and measurable clinical trial process that focuses on the safety and protection of its subjects and the production of timely and accurate clinical data.

We are a multidisciplinary membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management. Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results. As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!

Pharmacology Research Institute is a healthcare organization that focuses on meeting patient needs through quality care and improved access to investigational treatments.

Promedica International is a privately held, full service CRO providing clinical trials for the medical device, biotechnology and pharmaceutical industries. Founded in 1985, Promedica International, a woman-owned corporation, is headquartered in Orange County, California. We have successfully been providing exceptional value to our clients for over 35 years.

PROMETRIKA, LLC is a full-service clinical research organization serving the pharmaceutical and biotechnology industries in the areas of clinical operations, pharmacovigilance, data management, biostatistics, medical writing, and regulatory submissions. With our expertise and extensive experience in managing clinical trials, and analyzing and interpreting medical data, we serve as outsourcing partners to our client companies and institutions.

ProTrials Research, Inc., is a full-service clinical research organization (CRO) and woman-owned business headquartered in Los Gatos, CA, with clinical operations personnel located throughout North America and across the world. ProTrials works with sponsors in the pharmaceutical, biotechnology and medical device industries to deliver high-quality clinical development services in a wide range of therapeutic areas. Founded in 1996, ProTrials has been successfully supporting clinical research for over 27 years.

Psomagen, Inc., formerly Macrogen Corp, delivers genomic sequencing services to the clinical, academic, and consumer markets. Psomagen's labs are US-based and CLIA and CAP certified. Not only is the company accredited to perform the highest quality Sanger sequencing, Next-Generation Sequencing and Microarray Gene Analysis, it is also networked with Macrogen's worldwide headquarters, stretching its capabilities and capacity across a diverse set of labs around the world. Learn more at psomagen.com.

Regenative Labs strives to process the highest quality human tissue allografts available in accordance with FDA and AATB requirements. Regenerative Medicine is a discipline that uses nature’s chemistry and biology to help the body repair itself.

Welcome and thank you for visiting the Rheumatology Associates of North Alabama. Our dedicated physicians, professional and friendly managers and staff mak

The Rose Research Center multisite clinical research company under the direction of Jed E. Rose, Ph.D. Dr. Rose has a legacy of societal influence by way of co-inventing the nicotine skin patch and other treatments for smoking cessation. His primary research goals are to elucidate the biological mechanisms underlying tobacco addiction and to promote the development of more effective treatments. The Rose Research Center operates two premier research facilities in North Carolina, leading the way in clinical trials to eliminate smoking addiction. RRC specializes in product innovation, product development, pharmaceutical testing and development, and cessation and addiction research. Facilities: Two offices, both over 2000sq ft. located in Raleigh and Charlotte, North Carolina. Full time Research Coordinators and technicians at both locations alongside M.D.'s and P.A.'s specifically trained in research. Participation: 10,000 subjects in a proprietary database and a reach to nearly 5M individuals in N.C. RRC utilizes advanced in-house marketing techniques to recruit. Successful recruitment strategies are formulated and executed by our marketing department using television commercials, print advertising, social media, and a powerful set of recruitment websites. Standard Equipment: Emergency AED and on-site portable oxygen, ECG machines, Carbon monoxide monitors, Breathalyzer, Pulse oximeters, Clinical freezer storage (-86°C/-20°C) with 24-hour power backup and temperature monitoring, Compact analytical balance, High-pressure programmable syringe pumps for device and cigarette testing, Refrigerated centrifuge, Nebulizer, CReSS smoking topography, Medical exam tables, Laboratories equipped for clinical trial specimen collection and processing, Isolation negative pressure room and telescopic ventilation arm for smoking studies adjacent to a second room with a telescopic ventilation arm, Video recording and two-way audio monitoring of subject sessions.

Rubix LS: The Health Outcomes Architect At Rubix LS, we drive innovation in clinical research, drug development, and public health by combining cutting-edge science, real-world data, and inclusive patient engagement. Our work is structured around three core pillars: 🔹 Investigator-Led Research – We conduct our own research and develop targeted solutions to accelerate new therapies and improve health outcomes. 🔹 Clinical Research Services – We collaborate with biotech, pharma, and life sciences companies to manage clinical trials, support regulatory submissions, and enhance patient diversity in research. Our work is powered by 18M patient data sets and 369M patient data points. 🔹 Government & Public Health – We partner with federal agencies and public health organizations to develop policies, improve disease surveillance, and advance health equity through data-driven solutions. Leveraging Environmental & Geographic Insights To better understand health risks and intervention strategies, we integrate: ✅ DoE data to analyze long-term environmental exposures. ✅ USDA data to study the impact of food and nutrition on health. ✅ Heat Sink data to model cancer risk and environmental disease patterns. At Rubix LS, we don't just conduct research—we build pathways to better health by ensuring therapies are developed, tested, and delivered with precision, equity, and impact. 🔗 Learn more at our website.

Rumi Scientific is a research-driven company focused on the discovery of drugs and innovative treatments for human genetic diseases. The company's mission is to fast-track the early stage of drug discovery using predictive models of the human brain for therapeutic success.

Sage Science products are built on the idea that science is more robust and reliable when it is based on high-precision, automated, reproducible technology instead of manually intensive steps that introduce variability and error. We look at molecular biology workflows and identify high-value steps that can be significantly improved with accurate, automated solutions. Our products not only reduce hands-on time and boost throughput, but they also improve data quality and downstream results for life science and diagnostic labs. The Sage Science portfolio includes products to perform DNA or cDNA size selection: Pippin Prep for short-read NGS platforms and the BluePippin for short and long-read NGS platforms. The SageELF provides whole-sample fractionation of DNA for various applications. The SageHLS offers a new twist on DNA target enrichment. DNA is first extracted from cells directly on the platform. Then Cas9 endonuclease/guide RNA complexes are used to excise and collect large targets (entire genes or genomic regions, up to 500MB in length) from a genome. Large target enrichment, called CATCH (Cas9 assisted targeting of chromosomal segments) is used to elucidate difficult genomic structures such as pseudogenes, SVs, and repeat elements. Sage Science is privately funded. It is headquartered and manufactures at 500 Cummings Center in Beverly, MA, USA.

Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development. Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers – including metabolites, lipids, and proteins – across thousands of samples at a time. These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data; robust quality control analysis; and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures. Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.

Science 37's mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration.

An oncology-focused Contract Research Organization (CRO) based in La Jolla, California. SciQuus Oncology offers a broad range of services to the pharmaceutical and biotechnology sectors. The experience of SciQuus management spans the development lifecycle from pre-IND studies to the management of large registration trials.

Our Clinical Operations Oversight Solution ClinOps Pro, simplifies clinical trial oversight by consolidating inputs from all data sources and efficiently producing accurate, updated dashboards and trackers to facilitate critical decision making.

Founded in 2007, Spaulding Clinical is a full-service, state-of-the-art paperless Phase I clinical pharmacology unit. Our facility, originally a hospital, features fully integrated bedside electronic data capture and sets the standard for patient care. We specialize in IND-enabling clinical pharmacology studies, cardiovascular safety, and clinical proof of concept. We provide expertise on study design, offering in-house medical writing, clinical data management, biostatistics, project management, clinical laboratory, and PK/PD analysis. For high-quality data to inform your decisions, Think Spaulding First. To learn more, visit spauldingclinical.com.

Springfield Clinic is dedicated to preserving the trusted patient-provider relationships we have carefully developed through 84 years of serving you with reliable, primary and specialized health care— close to home. We value the relationships we have built with all of you and are dedicated to preserving the quality and convenience of compassionate health care that you expect and deserve. Our mission is to deliver the highest quality patient care and experience at an exceptional value by recruiting and retaining top medical talent and specialists. We offer the latest innovative treatments and state-of-the-art technologies that would traditionally require treatment in a much larger metropolitan medical center, like St. Louis or Chicago. Our physicians, nurses and employees live, work and take great pride in the 20 counties we serve in central Illinois. We are a community-based organization with more than 650 physicians and advanced practice practitioners delivering care in over 80 medical specialties and sub-specialties. As one of the largest private multispecialty medical clinics in the state, we employ more than 3,000 clinical and administrative employees.

Starget Pharma is a clinical stage company developing a pipeline of radioligand therapy programs generated using its proprietary Backbone Dynamics peptide platform that leverages backbone cyclic innovations and in-silico AI to rapidly design highly specific Smart Targeted Radioligands (STRs) that deliver focused radiation for the imaging and treatment of hard-to-treat cancers.

Read the eBook on Navigating R&D: https://www.starlims.com/navigating-research-and-development-guide/ **One partner, powerful informatics solutions.** STARLIMS is a recognized leader in enterprise laboratory informatics, providing customers around the world with digital solutions for R&D and quality labs. With nearly four decades as in informatics, STARLIMS is in the business of delivering results. 🌐 2,000+ Labs Worldwide 👥 1,100+ Customers 🌍 85+ Countries 🔬 LIMS, SDMS, LES, and Advanced Analytics 🏆 Leader on G2 💡 With the intuitive cloud Labstep Electronic Lab Notebook (ELN) STARLIMS is your one true partner in lab informatics from R&D through to commercialization 🌟 Industry Solutions: 🧪 Life Sciences 🏭 Contract Development Manufacturing Organizations (CDMOs) 🍔 Food & Beverage ⚗️ Chemical 🍃 Agrochemical ⛽ Oil & Gas 🛍️ Consumer Goods 📝 Contract Testing, 🏥 Public Health 🩺 Clinical Diagnostics We're committed to providing quality products and services that help our customers reach their goals. Whether your mission is to discover a breakthrough drug, protect the health of the population, or get safe toys to market, we're here to support you.

SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. With industry leading strategic consulting and clinical biometrics solutions expertise at our core, our technology enabled services are fully scalable and supported via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC Empowers Clinical Decisions.

Sun Valley Research Center, Inc. has emerged from having the privilege of practicing for years in a rural area close to the Mexican border, combined with our commitment to the community and our passion for excellence in research and patient care. SVRC, Inc. started in October 2007 and since then we have worked on over 70 study drug clinical trials and over 10 observational or genetic trials. Our dedicated research site has 4 consultation rooms, 1 physical exam room, 1 EKG room, 2 laboatory areas for blood draws and processing of samples, 1 conference room for research meetings or monitors. Clinical research staff we have is our PI Dr. Bernardo Ng a board certified psychiatrist and rater, several Sub Investigator's (M.D.'s, NP's, LMFT's), 2 full time study coordinators, IATA trained and one who is a phlebotomist, 1 full time Director of Research Judy Galindo who is a certified clinical research coordinator through ACRP, 2 Research Assistants who are also IATA trained and 1 Marketing & Outreach representative. All equipment is calibrated every February and all staff are up to date with all trainings including GCP and our site SOP's. Al starff are Bilingual (English/Spanish) and Fluent and the majority of our patient population is Hispanic in our community. Due to our patient demographics we work with both English and Spanish patients and we strive to contribute diversity in clinical trials. We have established relationships with local physicians in various therapeutic areas as well as local community clinics and the county mental health office. Our marketing and outreach representative is out daily educating the community about clincial research and establishing new relationships with people and organizations and finding potential participants for our trials. Site Contact: Judy Galindo, CCRC Email: judy@sunvalleyb.com Direct Office #(760) 355-0176

Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.

The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, creating one of the world's largest specialized dermatology-focused clinical research organizations. Founded over 20 years ago, the Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client's dermatology and aesthetics services - from pre-clinical formulation work to subsequent clinical trial execution. Proinnovera was founded 25 years ago and is a leading European CRO in the dermatology clinical trial space. It is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Their combined strength will enable them to excel at addressing customers' needs and expectations in all areas of research. The newly formed organization will leverage the combined power of two highly experienced teams with deep expertise in the dermatology space to generate efficiencies and accelerate clinical research. Symbio Proinnovera will be supported in its growth by ARCHIMED, a leading investment firm focused exclusively on healthcare industries.

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

We are an independent, full-service, family-owned CRO specializing in dermatology since 1944. We manage global phase 2/3 trials in conjunction with our standalone phase I unit. Our structure and experience allow us to approach each and every study with agility and innovation, providing our sponsors with a truly bespoke turnkey solution. We are not your traditional CRO.

We are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel. With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. Our Drug-Gene Atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. Our proprietary artificial intelligence modeling suite, Conductor AI, used our Drug-Gene Atlas to discover and predict the effects of new drugs at transcriptome scale.

TriWest Research Associates is a Medical Research Center that conducts high-quality clinical trials to support the biopharmaceutical and scientific research community.

Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing innovative systems to leverage expansive site, patient, and historical performance data. To learn more about how Velocity delivers high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale, visit VelocityClinical.com.

Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically cheaper trials and computationally designed therapeutics.

Vibrant Wellness is a leading CLIA-certified lab testing company based in Santa Clara, CA. We have the largest selection of comprehensive specialty lab tests, trusted by over 18,0000 wellness professionals. Our precision technology helps providers discover the root of patient symptoms with highly sensitive and accurate testing, enabling individualized root-cause treatment plans for optimal health and longevity. We were born out of a vision to transform the way healthcare is delivered by providing healthcare providers with more innovative and efficient diagnostic tools. Founded in Silicon Valley in 2011, we're a pioneer in specialty testing that pushes the boundaries of what's possible in personalized wellness. Our mission is to empower clinicians with the precise insights they need to uncover the root causes of patient symptoms, enabling truly individualized treatment plans that drive optimal health and longevity. At the heart of our work is a dedication to innovation and scientific excellence. Our proprietary 3Dense microarray technology is a testament to this, offering enhanced clinical sensitivity and specificity while allowing for small sample sizes and high-volume processing. With over 400 clinical researchers and scientists on our team, we redefine what's possible in diagnostics."

VIDA is a clinical imaging intelligence company that is accelerating the approval and adoption of life-saving therapies to patients through an AI-powered digital biomarker solution. With proprietary imaging biomarkers for precise quantitative endpoints and a trial imaging management solution, VIDA's solution is helping biopharma sponsors save millions in drug development costs.

Vivid Genomics enables pharma companies to select and stratify the right patients for their clinical trials, increasing the probability of trial success and getting to an approved drug. We use machine learning and genomics to develop blood-based, genetic tests (“Genomic BiopsyTM”) for neurodegenerative diseases, beginning with Alzheimer’s.

M3 Wake Research is a premier clinical trial network that has been conducting studies since 1984. With over 30 years of experience, the network's subject database for clinical trial participants has substantial potential and continues to expand as we grow our network across the country. The network comprises of premier investigational sites that are fully integrated and designed to deliver superior clinical trial experiences to patients, sponsors, and CROs. M3 Wake Research offers a full range of clinical trial services, from study design to study completion, to meet the needs of global biopharmaceutical, biotechnology, medical device, and pharmaceutical industry leaders. The board-certified physicians of M3 Wake Research have successfully completed over 7,000 clinical trials with integrity, human protection, and expeditious delivery of accurate evaluable data. Experience M3 Wake Research's uncompromising approach to superior quality in planning and executing each study according to regulations. The network consistently exceeds sponsor expectations for integrity, subject enrollment, human protection, and expeditious delivery of accurate evaluable data. Choose M3 Wake Research for clinical trials that meet and exceed your expectations.

WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG's 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy while improving quality outcomes and efficiency through the process. Ninety percent of all clinical trials leverage our knowledge, highly specialized solutions, and data-driven insights to mitigate risk today for a more promising tomorrow.

Westat offers innovative professional services to help clients improve outcomes in health, education, social policy, and transportation. We are dedicated to improving lives through research. Expertise • Data Collection & Management • Clinical Trials • Statistical Research & Survey Methods • Evaluation • Communications & Social Marketing Staff and Locations Westat’s staff of more than 2,000 are located at our headquarters in Rockville, Maryland, near Washington, DC. Additional staff are located at Westat’s data collection survey processing facilities, at our Telephone Research Center facilities, and throughout our nationwide field operations. Westat also maintains research offices near our clients in Atlanta, Georgia; Cambridge, Massachusetts; Raleigh/Durham, North Carolina; Philadelphia, Pennsylvania; Houston, Texas; and San Antonio, Texas. We have international offices in Liberia, Costa Rica; Johannesburg, South Africa; and Bangkok, Thailand. Westat is committed to providing accessible media on LinkedIn. Should you experience difficulties with any posted media, please send us a message at Section508Coordinator@westat.com. An alternative format will be provided upon request.

In 1991, Cheri Casey made the decision to begin her own medical research company. Stemming from her deep-rooted passion to continually seek better medicine. In 25 years of medical research, Western States Clinical Research (WSCR), Inc. has conducted over 150 research studies. This has contributed in a significant way to the advancement of current medications and the implementation of new ones. Some medications WSCR, Inc. participated in researching, that are worthy of mention according to the Director Cheri Casey, include Tudorza, Spiriva, Nicotine Patches and Humira. These drugs were researched in their early stages with the help of WSCR, Inc. and other sites across the country and around the world. Medical research is an integral step in the development of new medications. The purpose of medical research is to study the safety and efficacy of new medications before they are sold to the general- public. WSCR, Inc. conducts medical research studies in a wide variety of therapeutic fields. WSCR, Inc's team of clinical research coordinators have a wide breadth of medical and clinical experience. They are constantly striving to expand their knowledge and partake in continuing education to maintain certifications and stay at the cusp of innovation for the research and development field. Our website contains information for physicians, pharmaceutical companies and individuals interested in participating in clinical research. OUR MISSION is to protect human subjects by committing to the ethical conduct of medical research and adhering to regulatory expectations. Western States Clinical Research, Inc. works diligently to provide high quality research and usable data for use in the development of better medicine for all.

Wilson Wolf Manufacturing invents, designs, and manufactures innovative cell culture devices and associated ancillary products. Our mission is to create hope for cancer patients, one device at a time. G-Rex® bioreactors, our flagship product line, are uniquely suited for the rapid expansion of immune cell types for academic research and commercial cell therapy manufacturing. We focus on the revolutionary field of T cell therapy, which is generating impressive clinical outcomes for once incurable cancer types. Wilson Wolf has partnered with Fresenius Kabi and Bio-Techne to form ScaleReady, a marketing, technical support, and commercialization organization focused on providing the most scalable cell therapy manufacturing platform in the industry. The spirit of the partnership and the ScaleReady business allows us to simplify T cell manufacturing by offering the most innovative solutions in the industry, both immediately and into the future, through collaborative development of new products that address the challenges of scaling a cell therapy. Contact us with questions or to learn how our expertise in the field of T cell therapy manufacturing can help your organization develop commercially viable, highly reliable and repeatable manufacturing processes.

About Worldwide Clinical Trials  Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.